Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akira Shimatsu

Showing results (181-190 of 207) with videos related to

Pageof 21
Sort By:
Pituitary|November 7, 2015
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's diseaseMaria Fleseriu, Rosario Pivonello, Jacques Young, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 6, 2010
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndromeNoriko Satoh-Asahara, Takayoshi Suganami, Takafumi Majima, et al.
Pituitary|January 25, 2025
Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studiesMaria Fleseriu, Rosario Pivonello, John Newell-Price, et al.
Journal of Diabetes Investigation|November 19, 2016
Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assayTakashi Murata, Kokoro Tsuzaki, Shinsuke Nirengi, et al.
Endocrine Journal|April 21, 2011
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemiaTetsuya Tagami, Hironori Kimura, Sumire Ohtani, et al.
Plos One|December 30, 2011
Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjectsHiromichi Wada, Shuichi Ura, Shuji Kitaoka, et al.
European Journal of Endocrinology|August 18, 2022
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extensionMaria Fleseriu, John Newell-Price, Rosario Pivonello, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 3, 2014
No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH TreatmentToshiaki Tanaka, Kenji Fujieda, Susumu Yokoya, et al.
Journal of Gastroenterology|August 3, 2007
Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumorsTetsuhide Ito, Masao Tanaka, Hironobu Sasano, et al.
Clinical Endocrinology|March 3, 2015
Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronismHironobu Umakoshi, Kanako Tanase-Nakao, Norio Wada, et al.
Pageof 21

Showing results (181-190 of 207) with videos related to

Sort By:
Pageof 21
Pituitary|November 7, 2015
Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing's diseaseMaria Fleseriu, Rosario Pivonello, Jacques Young, et al.
Clinical Journal of the American Society of Nephrology : CJASN|November 6, 2010
Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndromeNoriko Satoh-Asahara, Takayoshi Suganami, Takafumi Majima, et al.
Pituitary|January 25, 2025
Osilodrostat improves blood pressure and glycemic control in patients with Cushing's disease: a pooled analysis of LINC 3 and LINC 4 studiesMaria Fleseriu, Rosario Pivonello, John Newell-Price, et al.
Journal of Diabetes Investigation|November 19, 2016
Diagnostic accuracy of the anti-glutamic acid decarboxylase antibody in type 1 diabetes mellitus: Comparison between radioimmunoassay and enzyme-linked immunosorbent assayTakashi Murata, Kokoro Tsuzaki, Shinsuke Nirengi, et al.
Endocrine Journal|April 21, 2011
Multi-center study on the prevalence of hypothyroidism in patients with hypercholesterolemiaTetsuya Tagami, Hironori Kimura, Sumire Ohtani, et al.
Plos One|December 30, 2011
Distinct characteristics of circulating vascular endothelial growth factor-a and C levels in human subjectsHiromichi Wada, Shuichi Ura, Shuji Kitaoka, et al.
European Journal of Endocrinology|August 18, 2022
Long-term outcomes of osilodrostat in Cushing's disease: LINC 3 study extensionMaria Fleseriu, John Newell-Price, Rosario Pivonello, et al.
Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|May 3, 2014
No Improvement of Adult Height in Non-growth Hormone (GH) Deficient Short Children with GH TreatmentToshiaki Tanaka, Kenji Fujieda, Susumu Yokoya, et al.
Journal of Gastroenterology|August 3, 2007
Preliminary results of a Japanese nationwide survey of neuroendocrine gastrointestinal tumorsTetsuhide Ito, Masao Tanaka, Hironobu Sasano, et al.
Clinical Endocrinology|March 3, 2015
Importance of contralateral aldosterone suppression during adrenal vein sampling in the subtype evaluation of primary aldosteronismHironobu Umakoshi, Kanako Tanase-Nakao, Norio Wada, et al.
Pageof 21